Why is Moderna stock up 87% today during premarket trade?
Covered by 1 source · 1 article
Moderna MRNA shares surged in premarket trading on Wednesday after the company said its mRNA vaccine, when combined with Merck's Keytruda immunotherapy, delivered positive results in a late-stage trial for skin cancer. At one point, before…
Covered by
